Vascular endothelial growth factor (VEGF) and its cousins, such as placental growth factor, have moved into the daily clinical arena. One-step-removed regulators, such as the VEGF splice variant soluble fms-like tyrosine kinase-1 (sFlt-1), now clinically emerge. sFlt-1 keeps our corneas 'clean.' However, sFlt-1 could also cause disease, such as preeclampsia. The report by Matsui et al. on ApoE and sFlt-1 gene-deleted mice could foster important subsequent research. We are limited only by our imaginations
Elevated circulating soluble fms-like tyrosine kinase 1 (sFLT-1) is associated with the development ...
Abstract Preeclampsia is a potentially life threatening disorder of pregnancy which presents with ra...
Preeclampsia is a maternal hypertensive disorder that affects up to 1 out of 12 pregnancies worldwid...
Imbalanced signaling between maternal and placental cells contributes to preeclampsia, suggests a ne...
Preeclampsia, a syndrome affecting 5% of pregnancies, causes substantial maternal and fetal morbidit...
One driving factor for developing preeclampsia-a pregnancy disorder, often associated with poor spir...
Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, ...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
In preeclampsia, the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFLT-1) is released f...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
(1) Background: Soluble Fms-like tyrosine kinase 1 (sFLT1) is an endogenous VEGF inhibitor. sFLT1 ha...
One driving factor for developing preeclampsia-a pregnancy disorder, often associated with poor spir...
Soluble fms-like tyrosine kinase-1 (sFlt1) is a truncated splice variant of Flt1, which is upregulat...
Elevated circulating soluble fms-like tyrosine kinase 1 (sFLT-1) is associated with the development ...
Abstract Preeclampsia is a potentially life threatening disorder of pregnancy which presents with ra...
Preeclampsia is a maternal hypertensive disorder that affects up to 1 out of 12 pregnancies worldwid...
Imbalanced signaling between maternal and placental cells contributes to preeclampsia, suggests a ne...
Preeclampsia, a syndrome affecting 5% of pregnancies, causes substantial maternal and fetal morbidit...
One driving factor for developing preeclampsia-a pregnancy disorder, often associated with poor spir...
Preeclampsia (PE) is characterized by widespread endothelial damage with hypertension, proteinuria, ...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
In preeclampsia, the antiangiogenic factor soluble fms-like tyrosine kinase-1 (sFLT-1) is released f...
The anti-angiogenic soluble fms-like tyrosine kinase 1 (sFLT1) is one of the candidates in the progr...
Background The angiogenic factors soluble fms‐like tyrosine kinase‐1 (sFlt‐1) and placental growth f...
(1) Background: Soluble Fms-like tyrosine kinase 1 (sFLT1) is an endogenous VEGF inhibitor. sFLT1 ha...
One driving factor for developing preeclampsia-a pregnancy disorder, often associated with poor spir...
Soluble fms-like tyrosine kinase-1 (sFlt1) is a truncated splice variant of Flt1, which is upregulat...
Elevated circulating soluble fms-like tyrosine kinase 1 (sFLT-1) is associated with the development ...
Abstract Preeclampsia is a potentially life threatening disorder of pregnancy which presents with ra...
Preeclampsia is a maternal hypertensive disorder that affects up to 1 out of 12 pregnancies worldwid...